MoneyWorks4Me

Trident Lifeline - Quaterly Results

19 Oct 2024 Evaluate
A decent increase of about 57.67% in the turnover to Rs. 156.61 millions was observed for the quarter ended September 2024. The turnover stood at Rs. 99.33 millions during the similar quarter previous year.Profit after tax for the quarter ended September 2024 reported a huge growth of 98.77% to Rs. 33.91  millions from Rs. 17.06 millions.Operating profit surged to 49.40 millions from the corresponding previous quarter of 25.71 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 156.61 99.33 57.67 303.98 185.76 63.64 446.52 316.92 40.89
Other Income 5.17 3.79 36.41 9.90 7.08 39.83 22.03 11.54 90.90
PBIDT 49.40 25.71 92.14 94.91 46.63 103.54 110.33 74.04 49.01
Interest 2.67 1.05 154.29 4.69 2.04 129.90 4.63 4.66 -0.64
PBDT 46.73 24.66 89.50 90.22 44.59 102.33 105.70 69.38 52.35
Depreciation 1.57 1.61 -2.48 4.83 2.94 64.29 7.70 3.65 110.96
PBT 45.16 23.05 95.92 85.39 41.65 105.02 98.00 65.73 49.09
TAX 11.25 5.99 87.81 21.35 10.57 101.99 27.56 5.61 391.27
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 3.71 5.19 -28.52
PAT 33.91 17.06 98.77 64.04 31.08 106.05 70.44 60.12 17.17
Equity 114.99 80.00 43.74 114.99 114.99 0.00 114.99 114.99 0.00
PBIDTM(%) 31.54 25.88 21.87 31.22 25.10 24.38 24.71 23.36 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..